Shigatoxin 1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Shigatoxin 1 monoclonal antibodies for research in understanding the mechanisms of Shigella infection. Shigatoxin 1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Shigatoxin 1, produced by Shigella dysenteriae, plays a critical role in the pathogenesis of shigellosis by inhibiting protein synthesis in host cells, leading to cell death and inflammation. The toxin affects intestinal epithelial cells directly and contributes to systemic complications in severe infections. Understanding Shigatoxin 1 function is essential for developing therapeutic strategies against Shigella infections. Research applications include studying toxin-host cell interactions, tracking infection progression, and evaluating potential treatment approaches. Investigating Shigatoxin 1 mechanisms helps reveal new therapeutic targets and diagnostic markers. Current studies focus on understanding cellular responses to Shigatoxin 1 and its role in disease development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of bacterial pathogenesis and developing new therapeutic strategies against Shigella infections.